v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Assets    
Cash and cash equivalents $ 53,322 $ 119,555
Cash held in escrow 3,921 49,091
Real estate inventories 1,339,082 1,121,726
Goodwill 155,597 68,639
Other assets 148,996 107,873
Total assets 1,701,337 1,471,232
Liabilities    
Accounts payable 86,348 77,969
Accrued expenses and other liabilities 212,645 160,256
Line of credit facility, net 194,435 307,631
Senior notes, net 530,919 236,143
Total liabilities 1,025,228 782,880
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.0001 par value, 50,000,000 shares authorized, none issued and outstanding as of December 31, 2024 and December 31, 2023, respectively 0 0
Common stock, $0.0001 par value, 500,000,000 shares authorized, 41,712,850 issued and 36,316,855 outstanding as of December 31, 2024, 41,382,453 issued and 36,520,894 outstanding as of December 31, 2023 4 4
Additional paid-in capital 462,363 465,290
Retained earnings 204,815 187,584
Total stockholders’ equity 667,182 652,878
Noncontrolling interests 8,927 35,474
Total equity 676,109 688,352
Total liabilities and equity 1,701,337 1,471,232
Related Party    
Assets    
Due from affiliates 419 4,348
Liabilities    
Notes Payable $ 881 $ 881

Source